Recro Pharma Inc (REPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

490 LAPP ROAD MALVERN, PA 19355

Recro Pharma, Inc is a specialty pharmaceutical company. The company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Recro Pharma offers its products to the medical industry.

Data based on most recent fiscal year report
Market Cap372.317 Million Shares Outstanding22.73 Million Avg Volume381.421 Thousand
1-Yr BETA vs S&P TR0.662 Current Ratio2.45 Quick Ratio2.08
View SEC Filings from REPH instead.

View recent insider trading info

Funds Holding REPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding REPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALTOMARI ALFRED

  • Director
33,382 2020-03-26 2

WEISMAN WAYNE

  • Director
40,582 2020-03-26 2

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • Director
4,310,689 2020-03-17 0

REASONS BRYAN M.

  • Director
8,876 2020-03-02 2

CHURCHILL WINSTON J

  • Director
76,810 2020-02-24 2

LAKE RYAN DAVID CHIEF FINANCIAL OFFICER

  • Officer
58,738 2020-02-03 5

HENWOOD GERALDINE PRESIDENT AND CEO

  • Officer
  • Director
387,887 2020-01-27 4

FLYNN KAREN PRES. BIOLOGICS & CCO

  • Officer
0 2020-01-08 2

AJDLER ARNAUD

  • Director
5,624,326 2020-01-03 3

LUDOMIRSKI ABRAHAM

  • Director
111,096 2020-01-02 0

BERELOWITZ MICHAEL

  • Director
41,260 2019-12-05 2

ASHTON WILLIAM

  • Director
27,782 2019-12-05 2

MATTILA JYRKI

  • Director
376 2019-05-22 0

CELANO MICHAEL DIRECTOR

62,642 2019-05-21 0

MYERS DIANE SENIOR VP-REG/QUALITY

  • Officer
18,528 2018-01-18 0

MACK RANDALL SENIOR VP, DEVELOPMENT

  • Officer
33,752 2018-01-18 0

MCCALLUM STEWART CHIEF MEDICAL OFFICER

  • Officer
31,841 2018-01-18 0

GRAFF FRED CHIEF COMMERCIAL OFFICER

  • Officer
27,083 2018-01-18 0

SCP VITALIFE PARTNERS (ISRAEL) II, L.P.

  • 10% Owner
726,055 2018-01-04 0

SCP VITALIFE PARTNERS II LP

  • 10% Owner
2,172,900 2018-01-04 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2017-06-12 0

STONEPINE CAPITAL MANAGEMENT, LLC

  • 10% Owner
No longer subject to file 2017-05-12 0

NICHOLS DONNA CAO/CONTROLLER

  • Officer
0 2017-01-18 0

GARNER CHARLES CFO AND CHIEF BUSINESS OFFICER

  • Officer
5,000 2015-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LAKE RYAN DAVID - Officer CHIEF FINANCIAL OFFICER

2020-02-03 A 12,000 a 58,738 58,738.00 direct

LAKE RYAN DAVID - Officer CHIEF FINANCIAL OFFICER

2020-02-03 A 45,000 a 45,000 58,738.00 direct

Elevate your investments